Juanjuan Huang
Overview
Explore the profile of Juanjuan Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
640
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qian G, Zan G, Li J, Meng D, Sun T, Thampy V, et al.
Adv Mater
. 2025 Mar;
37(10):e2416915.
PMID: 40072020
Lithium-ion batteries are indispensable power sources for a wide range of modern electronic devices. However, battery lifespan remains a critical limitation, directly affecting the sustainability and user experience. Conventional battery...
2.
Xie Y, Yang M, Huang J, Jiang Z
J Inflamm Res
. 2025 Jan;
18():701-722.
PMID: 39835298
Purpose: Intestinal ischemia-reperfusion injury (IIRI) occurs as a result of temporary blood flow interruption, leading to tissue damage upon reperfusion. Oxidative stress plays a critical role in this process, instigating...
3.
Feng B, Feng Y, Huang J, Liu T, Qin J
Lancet Oncol
. 2025 Jan;
26(1):e2.
PMID: 39756452
No abstract available.
4.
Chen H, He G, Huang J, Hu L, Ma J
Front Immunol
. 2025 Jan;
15:1495137.
PMID: 39742259
Introduction: Antibody-drug conjugates (ADCs) are increasingly utilized in patients with solid tumors and hematologic malignancies. However, the adverse ocular toxicity induced by ADCs has not been comprehensively evaluated in real-world...
5.
Sun J, Deng X, Huang J, He G, Huang S
PLoS One
. 2024 Dec;
19(12):e0316573.
PMID: 39739861
Nirmatrelvir/Ritonavir, acting as an effective agent against COVID-19, has achieved considerable results in clinical studies in terms of drug efficacy. However, there is little research about its medication safety. Based...
6.
Huang J, Jin Y, Wu R, Xie H, Yang M, Jia J, et al.
FASEB J
. 2024 Dec;
38(24):e70276.
PMID: 39718442
Multi-target strategy can serve as a valid treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but existing drugs most focus on a single target. Thus, multi-target drugs that bind...
7.
Ma J, Chen H, Sun J, Huang J, He G, Yang G
BMC Med Res Methodol
. 2024 Dec;
24(1):312.
PMID: 39707270
Background: Liver injury from drug-drug interactions (DDIs), notably with anti-tuberculosis drugs such as isoniazid, poses a significant safety concern. Electronic medical records contain comprehensive clinical information and have gained increasing...
8.
Feng B, Liu T, Feng Y, Huang J, Qin J
J Transl Med
. 2024 Nov;
22(1):1083.
PMID: 39614375
No abstract available.
9.
Xiong W, Li Y, Hu L, He G, Huang J
Front Pharmacol
. 2024 Nov;
15:1458500.
PMID: 39605908
Objectives: Over the years when disease-modifying antirheumatic drugs (DMARDs) have been used in rheumatoid arthritis patients, reports of malignancies have emerged. This study aims to investigate the association between malignancies...
10.
He Y, Shen L, Du J, Cao X, Zhang B, Wang D, et al.
Clin Microbiol Infect
. 2024 Oct;
31(2):290.e1-290.e3.
PMID: 39454755
Objectives: To determine the agreement of Mycobacterium tuberculosis (MTB) antigen-based skin test (TBST) with interferon-gamma release assay (IGRA) in the elderly individuals aged ≥65 years beyond instruction for use in...